
Mach7 Technologies Ltd
ASX:M7T

Intrinsic Value
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. [ Read More ]
The intrinsic value of one
M7T
stock under the Base Case scenario is
0.582
AUD.
Compared to the current market price of 0.725 AUD,
Mach7 Technologies Ltd
is
Overvalued by 20%.

Valuation History
Mach7 Technologies Ltd

Intrinsic Value History...
Our system is conducting in-depth analyses to map out the stock's valuation journey. Thank you for waiting.
Fundamental Analysis
Balance Sheet Decomposition
Mach7 Technologies Ltd
Current Assets | 34.9m |
Cash & Short-Term Investments | 23.4m |
Receivables | 10.6m |
Other Current Assets | 891k |
Non-Current Assets | 47.4m |
PP&E | 2m |
Intangibles | 35.5m |
Other Non-Current Assets | 10m |
Current Liabilities | 14.8m |
Accounts Payable | 3.4m |
Other Current Liabilities | 11.4m |
Non-Current Liabilities | 8m |
Long-Term Debt | 991k |
Other Non-Current Liabilities | 7m |
M7T Profitability Score
Profitability Due Diligence
Mach7 Technologies Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Score
Mach7 Technologies Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
M7T Solvency Score
Solvency Due Diligence
Mach7 Technologies Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Score
Mach7 Technologies Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
M7T Price Targets Summary
Mach7 Technologies Ltd
According to Wall Street analysts, the average 1-year price target for
M7T
is 1.298 AUD
with a low forecast of 1.111 AUD and a high forecast of 1.617 AUD.
Shareholder Return
M7T Price
Mach7 Technologies Ltd
Average Annual Return | 66.23% |
Standard Deviation of Annual Returns | 114.55% |
Max Drawdown | -71% |
Market Capitalization | 174m AUD |
Shares Outstanding | 240 866 047 |
Percentage of Shares Shorted |
N/A
|
Company Profile


Country
Industry
Market Cap
Dividend Yield
Description
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.
Contact
IPO
Employees
Officers
The intrinsic value of one
M7T
stock under the Base Case scenario is
0.582
AUD.
Compared to the current market price of 0.725 AUD,
Mach7 Technologies Ltd
is
Overvalued by 20%.